Could a probiotic boost antidepressants? new trial tests Gut-Brain mood link

NCT ID NCT07691749

First seen Jul 09, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests whether adding a specific blend of two probiotics (Lactobacillus helveticus and Bifidobacterium longum) to standard antidepressant medication helps reduce depression symptoms more than antidepressants alone. Adults aged 18 to 60 with major depressive disorder who are already on a stable dose of an SSRI antidepressant will take either the probiotic or a placebo capsule daily for six weeks. Researchers will measure changes in depression scores and monitor safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Lactobacillus helveticus and Bifidobacterium longum (psychobiotic probiotic blend)
What this could lead to
If it works, this could point toward a simple, safe add-on treatment that boosts the effectiveness of standard antidepressants for major depression.
What could go wrong
This is a small, early-stage trial. The probiotic may not outperform placebo, and results may not apply to all people with depression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Allama Iqbal Medical College, Jinnah Hospital Lahore

    RECRUITING

    Lahore, Punjab Province, 54550, Pakistan

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.